World Healthcare Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.

Press releases published on May 4, 2026

May 4, 2026

Brainway Launches Personalized Anti-Procrastination App Grounded in CBT, Earns 6,000+ User Reviews

Indeterminate GlobeNewswire

May 4, 2026

Mapi Pharma Explores U.S. Aseptic Manufacturing Facility to Support Growing Demand for Aseptic and Long-Acting Generic and innovative Injectables

Indeterminate GlobeNewswire

May 4, 2026

Abeona Therapeutics® Announces Date of First Quarter Financial Results

Indeterminate GlobeNewswire

May 4, 2026

Sienna Continues Platform Growth

Indeterminate GlobeNewswire

May 4, 2026

Dentsply Sirona Launches Smart View - Detect, World’s First FDA-Cleared AI-enabled diagnostic aid for detecting teeth with Periapical Radiolucencies in CBCTs

Indeterminate GlobeNewswire

May 4, 2026

FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

Indeterminate GlobeNewswire

May 4, 2026

Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8:30 AM ET

Indeterminate GlobeNewswire

May 4, 2026

Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

Indeterminate GlobeNewswire

May 4, 2026

NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress

Indeterminate GlobeNewswire

May 4, 2026

Serefin Health Launches MyCareSteps Program to Support Care Coordination Across Grey Bruce

Indeterminate GlobeNewswire

May 4, 2026

Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting

Indeterminate GlobeNewswire

May 4, 2026

ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026

Indeterminate GlobeNewswire

May 4, 2026

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

Indeterminate GlobeNewswire

May 4, 2026

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

Indeterminate GlobeNewswire

May 4, 2026

CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting

Indeterminate GlobeNewswire

May 4, 2026

Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026

Indeterminate GlobeNewswire

May 4, 2026

Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting

Indeterminate GlobeNewswire

May 4, 2026

Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society

Indeterminate GlobeNewswire

May 4, 2026

Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1

Indeterminate GlobeNewswire

May 4, 2026

Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer

Indeterminate GlobeNewswire